A clinical observation for the effect of "Quyu Huatan Xiezhuo" formulation in the treatment of patients with AMI
The popularization and application of treatment for intravenous thrombolysis and primary percutaneous coronary intervention, significantly reducing the incidence of complications and mortality in acute myocardial infarction (AMI), but how to reduce the occurrence of cardiac ischemic events and improve the long-term prognosis of patients, is still the.1996-1998 years of the hot issues of the cardiovascular disease prevention research field of blood stasis and phlegm diarrhea turbidity and the Yiqihuoxue treatment of AMI clinical comparison of observational studies, found that the blood stasis and phlegm diarrhea turbidity treatment of AMI, the reduction ofpatients with post-infarction angina, arrhythmias, heart failure, there is a definite advantage. are reported below.
